Hess, Juniper, Dow Chem: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Agrium ( AGU) downgraded at BofA Merrill from Buy to Neutral. $99 price target. Macro uncertainty, deal risks offset fundamental strength.

Arthur J. Gallagher ( AJG) upgraded at Brean from Hold to Buy. $35 price target. Company should see better rate momentum.

Cisco Systems ( CSCO) upgraded at Goldman to Buy. $21 price target. Street estimates may not be too conservative.

Citrix Sytems ( CTXS) upgraded at Morgan Stanley to Overweight. Stock is attractive, following a 24% decline since early June. $88 price target.

Dow Chemical ( DOW) upgraded at BofA Merrill from Underperform to Neutral. $42 price target. Solid guidance and strong risk/reward profile.

The Gap ( GPS) upgraded at Jefferies from Neutral to Buy. $25 price target. Valuation call as EPS expectations are low and sentiment negative.

Hess ( HES) downgraded at Deutsche Bank from Buy to Hold. $75 price target. Lack of significant near term catalysts.

Intrepid Potash ( IPI) upgraded at BofA Merrill from Neutral to Buy. $42 price target. Potash market set to strengthen, major catalysts at hand.

Juniper ( JNPR) downgraded at Citigroup from Buy to Hold. $27 price target. Weaker than expected results and long term growth remains cloudy.

Lennox ( LII) downgraded at UBS from Buy to Neutral. $38 price target. Lower visibility and revised outlook not clearly "beatable."

ManTech ( MANT) downgraded at Credit Suisse from Neutral to Underperform. $34 price target. Rising risk and uncertainty in the federal funding environment.

Nextera Energy ( NEE) downgraded at Baird to Neutral. Valuation call, based on a $59 price target.

Varian Medical ( VAR) downgraded at Baird to Neutral from Outperform, Robert Baird said. $72 price target. Company is seeing lower oncology orders.

Varian Medical numbers lowered at Goldman. Shares of VAR now seen reaching $57, according to Goldman Sachs. Estimates also cut, as the company is realizing slower growth. Sell rating.

End of report.

This article was written by a staff member of TheStreet.

More from Stocks

Stocks Slide on Renewed Trade War Concerns

Stocks Slide on Renewed Trade War Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Video: Here's Where to Put Your Money Amid Trade War Fears

Video: Here's Where to Put Your Money Amid Trade War Fears

The Single Biggest Reason Trade War Fears Could Finally Topple the Stock Market

The Single Biggest Reason Trade War Fears Could Finally Topple the Stock Market

Activist-Targeted Rent-A-Center Sold to Vintage

Activist-Targeted Rent-A-Center Sold to Vintage